HC Wainwright & Co. Maintains Buy on LifeMD, Lowers Price Target to $6

Benzinga · 1d ago
HC Wainwright & Co. analyst Yi Chen maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the price target from $9 to $6.